The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Sasanlimab (PF-06801591) added to BCG therapy significantly improved outcomes for patients with BCG-naive, high-risk ...

The most common symptom is blood in the urine. "Blood that is painless is usually a worse sign compared to blood associated ...

EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

Research by Nobel laureate Louis Ignarro and other scientists led to medications for heart diseases. Read more at ...

You may not have heard about orthobiologics, but the regenerative medicine may be your answer to treat pain coming from your ...

Scientists discovered that choanoflagellates coordinate their movements through electrical signaling via voltage-gated ...

Prolonged lack of sunlight can trigger more pronounced mood disturbances, including symptoms of depression and anxiety, ...

It turns out, according to a compelling new study, that cells in your kidneys and tendons can remember, meaning organs and ...

The heart’s natural healing ability is limited but groundbreaking research and advanced therapies are offering new hope for ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...